Generation and characterization of novel monoclonal antibodies to the Ret receptor tyrosine kinase

Biochemical and Biophysical Research Communications

Volumn 294, Issue 4, 2002, Pages 813-817

  Salvatore, Giuliana ^a,b   Nagata, Satoshi ^a   Billaud, Marc ^c   Santoro, Massimo ^b   Vecchio, Giancarlo ^b   Pastan, Ira ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

Author keywords

Ret antibody

Indexed keywords

HYBRID PROTEIN; MONOCLONAL ANTIBODY; PROTEIN RET; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; CONTROLLED STUDY; ENZYME GLYCOSYLATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; IMMUNIZATION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; DROSOPHILA PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLYCOSYLATION; HUMANS; HYBRIDOMAS; MICE; MICE, INBRED BALB C; NEOPLASMS; PRECIPITIN TESTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; RECOMBINANT FUSION PROTEINS;

EID: 0036292751     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(02)00560-0     Document Type: Article

References (21)

1. Of mice and men: Hybridoma and recombinant antibodies
2. Therapeutic monoclonal antibodies
3. Immunotoxins for targeted cancer therapy
4. Efficacy of the anti-CD22 recombinant immunotoxin BL22 in chemotherapy-resistant hairy-cell leukemia
5. Monoclonal antibodies
6. The RET proto-oncogene in human cancers
7. Specific expression of the Ret proto-oncogene in human neuroblastoma cell lines
8. Trk and Ret proto-oncogene expression in human neuroblastoma specimens: High frequency of trk expression in non-advanced stages
9. Expression of the Ret proto-oncogene in human neuro-blastoma cell lines and its increase during neuronal differentiation induced by retinoic acid
10. The Ret proto-oncogene is consistently expressed in human pheochromocytomas and thyroid medullary carcinomas
11. Regulation of cell fate decision of undifferentiated spermatogonia by GDNF
12. Glial cell line-derived neutrotrophic factor and neurturin can act as paracrine growth factors stimulating DNA synthesis of Ret-expressing spermatogonia
13. RET receptor expression in thyroid follicular epithelial cell-derived tumors
14. Expression and alternative splicing of c-ret RNA in papillary thyroid carcinomas
15. Identification of the Ret proto-oncogene products in neuroblastoma and leukemia cells
16. The RET receptor tyrosine kinase but not its specific ligand GDNF is preferentially expressed by acute leukaemias of monocytic phenotype and is up-regulated upon differentiation
17. Implication of expression of GDNF/Ret signalling components in differentiation of bone marrow haemopoietic cells
18. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B
19. Improved cytotoxic activity toward cell lines and fresh leukemia cells of a mutant anti-CD22 immunotoxin obtained by antibody phage display
20. New cytotoxic agents and schedules for advanced breast cancer
21. Improved gene transfer to neuroblastoma cells by a monoclonal antibody targeting RET a receptor tyrosine kinase